Abivax S.A. Revenue And Operating Income
Abivax S.A. (ABVX) reported Revenue And Operating Income of EUR 4.57 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Income Statement › Other Income
ifrs-full:RevenueAndOperatingIncome · last filed 2026-03-23
- Abivax S.A. revenue and operating income for the quarter ending 2025-12-31 was 440.00K EUR, a 89.79% decline year-over-year.
- Abivax S.A. revenue and operating income for the quarter ending 2025-09-30 was 2.04M EUR, a 54.31% increase year-over-year.
- Abivax S.A. revenue and operating income for the quarter ending 2025-06-30 was 1.09M EUR, a 80.58% decline year-over-year.
- Abivax S.A. revenue and operating income for the quarter ending 2025-03-31 was 994.00K EUR, a 16.19% decline year-over-year.
| Period end | Revenue And Operating Income 3 month | Revenue And Operating Income 6 month | Revenue And Operating Income 9 month | Revenue And Operating Income 12 month |
|---|---|---|---|---|
| 2025-12-31 | 440.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-03-23 | 2.48M EUR derived: sum of 2 quarters · filed 2026-03-23 | 3.58M EUR derived: sum of 3 quarters · filed 2026-03-23 | 4.57M EUR 20-F · filed 2026-03-23 |
| 2025-09-30 | 2.04M EUR 6-K · filed 2025-12-15 | 3.14M EUR derived: sum of 2 quarters · filed 2025-12-15 | 4.13M EUR 6-K · filed 2025-12-15 | 8.44M EUR derived: sum of 4 quarters · filed 2026-03-23 |
| 2025-06-30 | 1.09M EUR 6-K · filed 2025-09-08 | 2.09M EUR 6-K · filed 2025-09-08 | 6.40M EUR derived: sum of 3 quarters · filed 2026-03-23 | 7.72M EUR derived: sum of 4 quarters · filed 2026-03-23 |
| 2025-03-31 | 994.00K EUR 6-K · filed 2025-06-02 | 5.30M EUR derived: sum of 2 quarters · filed 2026-03-23 | 6.63M EUR derived: sum of 3 quarters · filed 2026-03-23 | 12.26M EUR derived: sum of 4 quarters · filed 2026-03-23 |
| 2024-12-31 | 4.31M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-03-23 | 5.63M EUR derived: sum of 2 quarters · filed 2026-03-23 | 11.26M EUR derived: sum of 3 quarters · filed 2026-03-23 | 12.45M EUR 20-F · filed 2026-03-23 |
| 2024-09-30 | 1.32M EUR 6-K · filed 2025-12-15 | 6.95M EUR derived: sum of 2 quarters · filed 2025-12-15 | 8.14M EUR 6-K · filed 2025-12-15 | |
| 2024-06-30 | 5.63M EUR 6-K · filed 2025-09-08 | 6.82M EUR 6-K · filed 2025-09-08 | ||
| 2024-03-31 | 1.19M EUR 6-K · filed 2025-06-02 | |||
| 2023-12-31 | 4.62M EUR 20-F · filed 2026-03-23 | |||
| 2022-12-31 | 4.58M EUR 20-F · filed 2025-03-24 | |||
| 2021-12-31 | 11.96M EUR 20-F · filed 2024-04-05 |